As new variants of COVID-19 disrupt global efforts to end the pandemic, governments need to work faster to immunise populations and curtail the spread. Samya Aboutajdine (International Growth Centre) examines lessons and policy solutions for global immunisation efforts, drawing from recent evidence on vaccine acceptance in low- and middle-income countries
Waiving intellectual property rights and donating vaccines are not enough to vaccinate the world qui...
Before the development of an effective vaccine, policymakers had to use other approaches such as mas...
Although randomized placebo-controlled trials (RCT) are critical to establish efficacy of vaccines a...
Vaccine apartheid has its roots in colonialism, write Sophie Harman (Queen Mary University of London...
Siva Thambisetty (LSE) reflects on the ongoing failure to increase countries’ access to COVID vaccin...
Before the development of COVID-19 vaccines to reduce the spread of the virus, US state and federal ...
The global effort to implement Covid-19 vaccination programmes poses substantial logistical challeng...
Waiving intellectual property protections for COVID-19 vaccines would help boost production and dist...
Siva Thambisetty reflects on the ongoing failure to increase countries’ access to COVID-19 vaccines,...
Richer countries are vaccinating their own citizens first. But leaving the rest without access to ja...
India, like other large countries, hopes its own vaccine, Covaxin, can help the nation find routes t...
With the emergence of a new strain of the virus that causes COVID-19 re-opening debates about the ec...
With the emergence of a new strain of the virus that causes COVID-19 re-opening debates about the ec...
For many people in rural South Sudan, the health impacts of COVID have been invisible, in contrast t...
Since the start of the pandemic, Pakistanis have become less likely to say they will accept a COVID ...
Waiving intellectual property rights and donating vaccines are not enough to vaccinate the world qui...
Before the development of an effective vaccine, policymakers had to use other approaches such as mas...
Although randomized placebo-controlled trials (RCT) are critical to establish efficacy of vaccines a...
Vaccine apartheid has its roots in colonialism, write Sophie Harman (Queen Mary University of London...
Siva Thambisetty (LSE) reflects on the ongoing failure to increase countries’ access to COVID vaccin...
Before the development of COVID-19 vaccines to reduce the spread of the virus, US state and federal ...
The global effort to implement Covid-19 vaccination programmes poses substantial logistical challeng...
Waiving intellectual property protections for COVID-19 vaccines would help boost production and dist...
Siva Thambisetty reflects on the ongoing failure to increase countries’ access to COVID-19 vaccines,...
Richer countries are vaccinating their own citizens first. But leaving the rest without access to ja...
India, like other large countries, hopes its own vaccine, Covaxin, can help the nation find routes t...
With the emergence of a new strain of the virus that causes COVID-19 re-opening debates about the ec...
With the emergence of a new strain of the virus that causes COVID-19 re-opening debates about the ec...
For many people in rural South Sudan, the health impacts of COVID have been invisible, in contrast t...
Since the start of the pandemic, Pakistanis have become less likely to say they will accept a COVID ...
Waiving intellectual property rights and donating vaccines are not enough to vaccinate the world qui...
Before the development of an effective vaccine, policymakers had to use other approaches such as mas...
Although randomized placebo-controlled trials (RCT) are critical to establish efficacy of vaccines a...